- Home
- OPAD vs DYAI Comparison
OPAD vs DYAI Comparison
Compare OPAD & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPAD
- DYAI
- Stock Information
- Founded
- OPAD 2015
- DYAI 1979
- Country
- OPAD United States
- DYAI United States
- Employees
- OPAD N/A
- DYAI N/A
- Industry
- OPAD Real Estate
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OPAD Finance
- DYAI Health Care
- Exchange
- OPAD Nasdaq
- DYAI Nasdaq
- Market Cap
- OPAD 25.3M
- DYAI 29.6M
- IPO Year
- OPAD N/A
- DYAI 2004
- Fundamental
- Price
- OPAD $1.49
- DYAI $0.97
- Analyst Decision
- OPAD Hold
- DYAI Strong Buy
- Analyst Count
- OPAD 5
- DYAI 1
- Target Price
- OPAD $2.38
- DYAI $6.00
- AVG Volume (30 Days)
- OPAD 133.6K
- DYAI 61.6K
- Earning Date
- OPAD 08-04-2025
- DYAI 08-12-2025
- Dividend Yield
- OPAD N/A
- DYAI N/A
- EPS Growth
- OPAD N/A
- DYAI N/A
- EPS
- OPAD N/A
- DYAI N/A
- Revenue
- OPAD $794,159,000.00
- DYAI $3,554,344.00
- Revenue This Year
- OPAD N/A
- DYAI $22.56
- Revenue Next Year
- OPAD $40.79
- DYAI $30.95
- P/E Ratio
- OPAD N/A
- DYAI N/A
- Revenue Growth
- OPAD N/A
- DYAI 57.59
- 52 Week Low
- OPAD $0.91
- DYAI $0.91
- 52 Week High
- OPAD $5.13
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- OPAD 73.82
- DYAI 45.26
- Support Level
- OPAD $0.91
- DYAI $0.91
- Resistance Level
- OPAD $1.59
- DYAI $0.99
- Average True Range (ATR)
- OPAD 0.13
- DYAI 0.06
- MACD
- OPAD 0.06
- DYAI 0.00
- Stochastic Oscillator
- OPAD 83.82
- DYAI 26.67
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.